BGMD BG Medicine Inc

USD 0.00 0.00 0
Icon

BG Medicine Inc (BGMD) Stock Analysis and Price Targets

COMMON STOCK | Medical Instruments & Supplies | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.0001

0.00 (0.00)%

USD 5.46K

N/A

N/A

N/A

Icon

BGMD

BG Medicine Inc (USD)
COMMON STOCK | OTC
USD 0.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 5.46K

N/A

USD 0.00

BG Medicine Inc (BGMD) Stock Forecast

N/A

Based on the BG Medicine Inc stock forecast from 0 analysts, the average analyst target price for BG Medicine Inc is not available over the next 12 months. BG Medicine Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BG Medicine Inc is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, BG Medicine Inc’s stock price was USD 0.0001. BG Medicine Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for BG Medicine Inc
No recent average analyst rating found for BG Medicine Inc

Company Overview BG Medicine Inc

BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galect...Read More

https://www.bg-medicine.com

303 Wyman Street, Waltham, MA, United States, 02451

5

December

USD

USA

Adjusted Closing Price for BG Medicine Inc (BGMD)

Loading...

Unadjusted Closing Price for BG Medicine Inc (BGMD)

Loading...

Share Trading Volume for BG Medicine Inc Shares

Loading...

Compare Performance of BG Medicine Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BGMD

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To BG Medicine Inc (Sector: Medical Instruments & Supplies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ESLOF
EssilorLuxottica Société ano.. -0.49 (-0.22%) USD103.18B 40.68 18.46

ETFs Containing BGMD

Symbol Name BGMD's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About BG Medicine Inc (BGMD) Stock

Stock Target Advisor's fundamental analysis for BG Medicine Inc's stock is Very Bearish.

Unfortunately we do not have enough data on BGMD's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BGMD's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BGMD's stock to indicate if its overvalued.

The last closing price of BGMD's stock was USD 0.00.

The most recent market capitalization for BGMD is USD 5.46K.

Unfortunately we do not have enough analyst data on BGMD's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains BG Medicine Inc's stock.

As per our most recent records BG Medicine Inc has 5 Employees.

BG Medicine Inc's registered address is 303 Wyman Street, Waltham, MA, United States, 02451. You can get more information about it from BG Medicine Inc's website at https://www.bg-medicine.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...